| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Internal Medicine, University of Genova Medical School, Genova, Italy
It has been recently shown that Fas ligand (FasL) expression on islet ß grafts results in neutrophilic infiltration and graft rejection. In this study, we show that human recombinant soluble FasL is endowed with potent chemotactic properties toward human neutrophilic polymorphonuclear leukocytes (neutrophils) at concentrations incapable of inducing cell apoptosis. Furthermore, neutrophils exposed to soluble FasL did not display detectable change of intracellular Ca2+ and did not undergo superoxide production or exocytosis of primary and secondary granules. Our results show that FasL is a potent chemoattractant for human neutrophils without evoking their secretory responses. This finding suggests a novel proinflammatory function for this ligand and may help to clarify the mechanism governing FasL-mediated graft rejection, thereby offering rational bases for controlling and modulating FasL-based immunotherapies.
This article has been cited by other articles:
|
|
 |
|
  S. D. Kim, J. M. Kim, S. H. Jo, H. Y. Lee, S. Y. Lee, J. W. Shim, S.-K. Seo, J. Yun, and Y.-S. Bae Functional Expression of Formyl Peptide Receptor Family in Human NK Cells J. Immunol., November 1, 2009; 183(9): 5511 - 5517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Buonocore, N. O. Haddou, F. Moore, S. Florquin, F. Paulart, C. Heirman, K. Thielemans, M. Goldman, and V. Flamand Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L J. Leukoc. Biol., September 1, 2008; 84(3): 713 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Loeffler, G. Le'Negrate, M. Krajewska, and J. C. Reed Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand J Natl Cancer Inst, August 6, 2008; 100(15): 1113 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Yolcu, X. Gu, C. Lacelle, H. Zhao, L. Bandura-Morgan, N. Askenasy, and H. Shirwan Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein J. Immunol., July 15, 2008; 181(2): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reardon, A. Wang, and D. M. McKay Transient Local Depletion of Foxp3+ Regulatory T Cells during Recovery from Colitis via Fas/Fas Ligand-Induced Death J. Immunol., June 15, 2008; 180(12): 8316 - 8326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Heinzelmann, V. Jendrossek, K. Lauber, K. Nowak, T. Eldh, R. Boras, R. Handrick, M. Henkel, C. Martin, S. Uhlig, et al. Irradiation-Induced Pneumonitis Mediated by the CD95/CD95-Ligand System. J Natl Cancer Inst, September 6, 2006; 98(17): 1248 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Lum, G. Bren, R. McClure, and A. D. Badley Elimination of Senescent Neutrophils by TNF-Related Apotosis-Inducing Ligand J. Immunol., July 15, 2005; 175(2): 1232 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Engelbert and M. S. Gilmore Fas Ligand but Not Complement Is Critical for Control of Experimental Staphylococcus aureus Endophthalmitis Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2479 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pieper, V. Nilakantan, M. Chen, J. Zhou, A. K. Khanna, J. D. Henderson Jr., C. P. Johnson, A. M. Roza, and C. Szabo Protective Mechanisms of a Metalloporphyrinic Peroxynitrite Decomposition Catalyst, WW85, in Rat Cardiac Transplants J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Alvarez, F. Prada, E. Salvatierra, A. I. Bravo, V. P. Lutzky, C. Carbone, F. J. Pitossi, H. E. Chuluyan, and O. L. Podhajcer Secreted Protein Acidic and Rich in Cysteine Produced by Human Melanoma Cells Modulates Polymorphonuclear Leukocyte Recruitment and Antitumor Cytotoxic Capacity Cancer Res., June 15, 2005; 65(12): 5123 - 5132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Soderstrom, S. D. Nyberg, and J. E. Eriksson CD95 capping is ROCK-dependent and dispensable for apoptosis J. Cell Sci., May 15, 2005; 118(10): 2211 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan Induction of tolerance using Fas ligand: a double-edged immunomodulator Blood, February 15, 2005; 105(4): 1396 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Giroux and F. Denis CD1d-unrestricted human NKT cells release chemokines upon Fas engagement Blood, January 15, 2005; 105(2): 703 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ottonello, P. Gnerre, M. Bertolotto, M. Mancini, P. Dapino, R. Russo, G. Garibotto, T. Barreca, and F. Dallegri Leptin as a Uremic Toxin Interferes with Neutrophil Chemotaxis J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2366 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Matute-Bello, R. K. Winn, T. R. Martin, and W. C. Liles Sustained Lipopolysaccharide-Induced Lung Inflammation in Mice Is Attenuated by Functional Deficiency of the Fas/Fas Ligand System Clin. Vaccine Immunol., March 1, 2004; 11(2): 358 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zanin-Zhorov, R. Hershkoviz, I. Hecht, L. Cahalon, and O. Lider Fibronectin-Associated Fas Ligand Rapidly Induces Opposing and Time-Dependent Effects on the Activation and Apoptosis of T Cells J. Immunol., December 1, 2003; 171(11): 5882 - 5889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ghio, L. Ottonello, P. Contini, M. Amelotti, C. Mazzei, F. Indiveri, F. Puppo, and F. Dallegri Transforming growth factor-{beta}1 in supernatants from stored red blood cells inhibits neutrophil locomotion Blood, August 1, 2003; 102(3): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoves, S. W. Krause, D. Halbritter, H.-G. Zhang, J. D. Mountz, J. Scholmerich, and M. Fleck Mature But Not Immature Fas Ligand (CD95L)-Transduced Human Monocyte-Derived Dendritic Cells Are Protected from Fas-Mediated Apoptosis and Can Be Used as Killer APC J. Immunol., June 1, 2003; 170(11): 5406 - 5413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Askenasy, E. S. Yolcu, Z. Wang, and H. Shirwan Display of Fas Ligand Protein on Cardiac Vasculature as a Novel Means of Regulating Allograft Rejection Circulation, March 25, 2003; 107(11): 1525 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Yurovsky Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Enhances Collagen Production by Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Renshaw, J. S. Parmar, V. Singleton, S. J. Rowe, D. H. Dockrell, S. K. Dower, C. D. Bingle, E. R. Chilvers, and M. K. B. Whyte Acceleration of Human Neutrophil Apoptosis by TRAIL J. Immunol., January 15, 2003; 170(2): 1027 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ottonello, M. Cutolo, G. Frumento, N. Arduino, M. Bertolotto, M. Mancini, E. Sottofattori, and F. Dallegri Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines Rheumatology, November 1, 2002; 41(11): 1249 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2002; 169(3): 1561 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ottonello, G. Frumento, N. Arduino, M. Bertolotto, P. Dapino, M. Mancini, and F. Dallegri Differential regulation of spontaneous and immune complex-induced neutrophil apoptosis by proinflammatory cytokines. Role of oxidants, Bax and caspase-3 J. Leukoc. Biol., July 1, 2002; 72(1): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Igney and P. H. Krammer Immune escape of tumors: apoptosis resistance and tumor counterattack J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Parmar, R. Mahadeva, B. J. Reed, N. Farahi, K. A. Cadwallader, M. T. Keogan, D. Bilton, E. R. Chilvers, and D. A. Lomas Polymers of alpha 1-Antitrypsin Are Chemotactic for Human Neutrophils . A New Paradigm for the Pathogenesis of Emphysema Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shimizu, K. Fukuo, S. Nagata, T. Suhara, M. Okuro, K. Fujii, Y. Higashino, M. Mogi, Y. Hatanaka, and T. Ogihara Increased plasma levels of the soluble form of fas ligand in patients with acute myocardial infarction and unstable angina pectoris J. Am. Coll. Cardiol., February 20, 2002; 39(4): 585 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Joashi, S. M. Tibby, C. Turner, A. Mayer, C. Austin, D. Anderson, A. Durward, and I. A. Murdoch Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Weinberger, D. L. Laskin, T. M. Mariano, V. R. Sunil, C. J. DeCoste, D. E. Heck, C. R. Gardner, and J. D. Laskin Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants J. Leukoc. Biol., December 1, 2001; 70(6): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hohlbaum, M. S. Gregory, S.-T. Ju, and A. Marshak-Rothstein Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors J. Immunol., December 1, 2001; 167(11): 6217 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tourneur, B. Malassagne, F. Batteux, M. Fabre, S. Mistou, E. Lallemand, P. Lores, and G. Chiocchia Transgenic Expression of CD95 Ligand on Thyroid Follicular Cells Confers Immune Privilege upon Thyroid Allografts J. Immunol., August 1, 2001; 167(3): 1338 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Falcone, A. G. Rossi, R. Sharkey, A. P. Brown, D. I. Pritchard, and R. M. Maizels Ascaris suum-Derived Products Induce Human Neutrophil Activation via a G Protein-Coupled Receptor That Interacts with the Interleukin-8 Receptor Pathway Infect. Immun., June 1, 2001; 69(6): 4007 - 4018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Bae, H. Bae, Y. Kim, T. G. Lee, P.-G. Suh, and S. H. Ryu Identification of novel chemoattractant peptides for human leukocytes Blood, May 1, 2001; 97(9): 2854 - 2862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Camelo, J. Castellanos, M. Lafage, and M. Lafon Rabies Virus Ocular Disease: T-Cell-Dependent Protection Is under the Control of Signaling by the p55 Tumor Necrosis Factor Alpha Receptor, p55TNFR J. Virol., April 1, 2001; 75(7): 3427 - 3434. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. OBERHOLZER, A. OBERHOLZER, M. CLARE-SALZLER, and L. L. MOLDAWER Apoptosis in sepsis: a new target for therapeutic exploration FASEB J, April 1, 2001; 15(6): 879 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Roth, S. Isenmann, M. Nakamura, M. Platten, W. Wick, P. Kleihues, M. Bähr, H. Ohgaki, A. Ashkenazi, and M. Weller Soluble Decoy Receptor 3 Is Expressed by Malignant Gliomas and Suppresses CD95 Ligand-induced Apoptosis and Chemotaxis Cancer Res., March 1, 2001; 61(6): 2759 - 2765. [Abstract] [Full Text]
|
|
|
|
|
|
C. K. Behrens, F. H. Igney, B. Arnold, P. Moller, and P. H. Krammer CD95 Ligand-Expressing Tumors Are Rejected in Anti-Tumor TCR Transgenic Perforin Knockout Mice J. Immunol., March 1, 2001; 166(5): 3240 - 3247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Villunger, L. A. O'Reilly, N. Holler, J. Adams, and A. Strasser FAS Ligand, Bcl-2, Granulocyte Colony-Stimulating Factor, and p38 Mitogen-Activated Protein Kinase: Regulators of Distinct Cell Death and Survival Pathways in Granulocytes J. Exp. Med., September 5, 2000; 192(5): 647 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hohlbaum, S. Moe, and A. Marshak-Rothstein Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival J. Exp. Med., April 3, 2000; 191(7): 1209 - 1220. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
